Law360, New York (August 31, 2015, 11:53 AM EDT) -- On July 31, 2015, the U.S. Food and Drug Administration issued a cybersecurity alert to health care facilities currently using certain infusion pumps manufactured by Hospira Inc. The alert warns health care facilities about security vulnerabilities in Hospira's Symbiq Infusion System (Version 3.13 and prior) that could allow unauthorized access to the device and interfere with the device's proper functioning. The Hospira device communicates with a health care facility's network and information systems to control dosage delivery. According to the alert, an unauthorized user could potentially access the Hospira device remotely and alter the dosage it delivers, which could lead to overinfusion or underinfusion of critical patient treatments. The FDA strongly encourages health care facilities to transition to alternative infusion systems and discontinue use of this particular Hospira infusion pump....